Neutrophils, Helicobacter pylori, and nonsteroidal anti-inflammatory drug ulcers.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Gastroenterology

• Publication date

  1999-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0016-5085(99)70120-4PMID 9922304
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

  1999cited by this paper
• Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers.

  1997cited by this paper
• NO‐naproxen vs. naproxen: ulcerogenic, analgesic and anti‐inflammatory effects

  1997cited by this paper
• Famotidine for healing and maintenance in nonsteroidal anti-inflammatory drug-associated gastroduodenal ulceration.

  1997cited by this paper
• Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs.

  1996cited by this paper
• Cytoprotective effects of CI-959 in the rat gastric mucosa: modulation of leukocyte adhesion.

  1995cited by this paper
• NSAIDs, Cox-2 inhibitors, and the gut.

  1995cited by this paper
• Interaction of NSAIDs and Helicobacter pylori on gastrointestinal injury and prostaglandin production: a controlled double‐blind trial

  1995cited by this paper
• Effect of longterm misoprostol coadministration with non-steroidal anti-inflammatory drugs: a histological study.

  1995cited by this paper
• Misoprostol Reduces Serious Gastrointestinal Complications in Patients with Rheumatoid Arthritis Receiving Nonsteroidal Anti-Inflammatory Drugs

  1995cited by this paper
• The proton pump inhibitor omeprazole inhibits acid survival of Helicobacter pylori by a urease-independent mechanism.

  1994cited by this paper
• Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs.

  1994cited by this paper
• The proton pump inhibitor omeprazole inhibits acid survival of Helicobacter pylori by a urease-independent mechanism.

  1994cited by this paper
• Ranitidine in the prevention of non‐steroidal anti‐inflammatory drug‐associated gastric and duodenal ulceration in arthritic patients

  1994cited by this paper
• Chemical gastritis and Helicobacter pylori related gastritis in patients receiving non-steroidal anti-inflammatory drugs: comparison and correlation with peptic ulceration.

  1992cited by this paper
• The Sydney System: Histological division

  1991cited by this paper
• Effect of Helicobacter pylori infection on the severity of gastroduodenal mucosal injury after the acute administration of naproxen or aspirin to normal volunteers.

  1991cited by this paper
• Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil-dependent process.

  1990cited by this paper
• Ethanol enhances leukocyte-endothelial cell interactions in mesenteric venules.

  1990cited by this paper
• Leukocyte adherence to venular endothelium during ischemia-reperfusion.

  1989cited by this paper

• The Fifth Mexican consensus on the diagnosis and treatment of Helicobacter pylori infection.

  2025cites this paper
• V consenso mexicano sobre el diagnóstico y tratamiento de la infección por Helicobacter pylori

  2025cites this paper
• Helicobacter pylori infection and gastroduodenal lesions in patients with systemic lupus erythematosus

  2019cites this paper
• Impact of reactive oxygen species generation on Helicobacter pylori-related extragastric diseases: a hypothesis

  2017cites this paper
• The relationship between Rheumatoid Arthritis and prevalence of Cytomegalovirus and Helicobacter pylori

  2017cites this paper
• Application of piper betle as an antioxidant against nonsteroidal anti-inflammatory drug-induced gastric ulcer

  2016cites this paper
• Evaluation of anti-Helicobacter pylori IgG level in the serum of patients with Rheumatoid arthritis

  2014cites this paper
• Wpyw farmakologicznej modyfikacji reakcji zapalnej na wyniki leczenia zapalenia żo¯ądka wywoanego zaka żeniem Helicobacter pylori

  2014cites this paper
• Antiadhesion and anti-inflammation effects of noni (Morinda citrifolia) fruit extracts on AGS cells during Helicobacter pylori infection.

  2014cites this paper
• Molecular pathogenesis of gastric ulcers and strategies for prevention

  2012cites this paper
• Biphasic effects of H. pylori infection on low-dose aspirin-induced gastropathy depending on the gastric acid secretion level

  2012cites this paper
• 484 Paradoxical Effects of H. pylori Infection on Low-Dose Aspirin Induced Gastropathy Depending on the Gastric Acid Secretion Level

  2012cites this paper
• 5-Lipoxygenase Metabolic Contributions to NSAID-Induced Organ Toxicity

  2012cites this paper
• Gastric Ulcer's Diseases Pathogenesis, Complications And Strategies For Prevention

  2011cites this paper
• Interaction of Helicobacter pylori Infection and Nonsteroidal Anti‐Inflammatory Drugs in Gastric and Duodenal Ulcers

  2010cites this paper
• Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial.

  2009cites this paper
• Helicobacter pylori Eradication in Patients on Long-term Treatment With NSAIDs Reduces the Severity of Gastritis: A Randomized Controlled Trial

  2009cites this paper
• Peptic-ulcer disease.

  2008cites this paper
• Frequency of NSAID induced peptic ulcer disease.

  2006cites this paper
• Influence of COX-2 and local cytokine expressions in gastric ulcer mucosa by H. pylori and NSAID.

  2006cites this paper
• Prévention primaire des ulcères gastro‐duodénaux avec l’aspirine faible dose ? Une question sans réponse

  2005cites this paper
• Gastrointestinal Inflammatory Diseases: Role of Chemokine

  2005cites this paper
• NSAID-Induced Peptic Ulcers and Helicobacter pylori Infection

  2005cites this paper
• Should we eradicate Helicobacter pylori in non‐steroidal anti‐inflammatory drug users?

  2004cites this paper
• [Pathogenesis of gastroduodenal lesions induced by non-steroidal anti-inflammatory drugs].

  2004cites this paper
• Changes in Helicobacter pylori status in patients with rheumatoid arthritis under non‐steroidal anti‐inflammatory drugs

  2004cites this paper
• NSAID Gastric Ulceration: Predictive Value of Gastric pH, Mucosal Density of Polymorphonuclear Leukocytes, or Levels of IL-8 or Nitrite

  2004cites this paper
• Efficacy and Safety of Ibuprofen Arginine in the Treatment of Primary Dysmenorrhoea

  2004cites this paper
• Physiopathologie des lésions gastro-duodénales induites par les anti-inflammatoires non stéroïdiens

  2004cites this paper
• Impact de l’infection à Helicobacter pylori sur le risque de complications gastro-duodénales des traitements anti-inflammatoires non stéroïdiens

  2004cites this paper
• Asymptomatic gastritis in naproxen‐treated North Indian children with juvenile rheumatoid arthritis

  2004cites this paper
• Sekundär- und Primärprophylaxe der ASS-/NSAR-Gastropathie: Eine Übersicht anhand vier klinischer Szenarien

  2003cites this paper
• [An overview of acetic acid ulcer models and their utility for drug screening].

  2003cites this paper
• [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].

  2003cites this paper
• Novel diagnostic method of testing for Helicobacter pylori infection using the rapid leukocyte strip test, Leukostix

  2003cites this paper
• Helicobacter pylori and non-steroidal anti-inflammatory drugs: the debate is over

  2003cites this paper
• [Should Helicobacter pylori infection be tested and eradicated in patients treated or about to be treated with aspirin or nonsteroidal anti-inflammatory drugs?].

  2003cites this paper
• Effect of Helicobacter pylori-mediated inflammation on nonsteroidal anti-inflammatory drugs-induced gastric mucosal injury.

  2002cites this paper
• Aspirin injury and H pylori

  2002cites this paper
• Helicobacter pylori infection potentiates aspirin induced gastric mucosal injury in Mongolian gerbils

  2002cites this paper
• Helicobacter pylori infection in rheumatoid arthritis: effect of drugs on prevalence and correlation with gastroduodenal lesions.

  2002cites this paper
• Influence of Helicobacter pylori Infection on Healing and Relapse of Acetic Acid Ulcers in Mongolian Gerbils

  2002cites this paper
• Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine

  2002cites this paper
• Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis.

  2002cites this paper
• Critical Effect of Helicobacter pylori Infection on the Effectiveness of Omeprazole for Prevention of Gastric or Duodenal Ulcers Among Chronic NSAID Users

  2002cites this paper
• Gastrointestinal safety and tolerability of nonselective nonsteroidal anti-inflammatory agents and cyclooxygenase-2-selective inhibitors.

  2002cites this paper
• Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial.

  2002cites this paper
• The effect of Helicobacter pylori infection on nonsteroidal anti‐inflammatory drug‐induced upper gastrointestinal tract injury

  2002cites this paper
• Peptic ulcer disease.

  2002cites this paper
• Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine.

  2002cites this paper
• SeminarPeptic-ulcer disease

  2002cites this paper
• Helicobacter pylori and nonsteroidal anti-inflammatory drugs: a three-way debate.

  2001cites this paper
• Cyclooxygenase 2—implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives

  2001cites this paper
• The Effect of Helicobacter Pylori Eradication on NSAID-Induced Gastrointestinal Toxicity

  2001cites this paper
• Non-steroidal anti-inflammatory drugs and gastrointestinal damage—problems and solutions

  2001cites this paper
• Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs.

  2001cites this paper
• Effects of Diacerein on Indomethacin-Induced Gastric Ulceration

  2001cites this paper
• Helicobacter pylori and nonsteroidal anti-inflammatory drugs. Approaching the end of the controversy in the new millennium, or room for more debate?

  2001cites this paper
• Interaction Between Helicobacter pylori Infection and NSAID Use

  2001cites this paper
• Factores de riesgo para la recurrencia de úlcera péptica

  2001cites this paper
• Comparison of CXC Chemokines ENA-78 and Interleukin-8 Expression in Helicobacter pylori-Associated Gastritis

  2001cites this paper
• Helicobacter pylori and NSAIDs--what interaction.

  2001cites this paper
• Reactive oxygen metabolites and upper gastrointestinal diseases.

  2001cites this paper
• Helicobacter pylori and nonsteroidal anti-inflammatory drugs.

  2001cites this paper
• Helicobacter pylori infection in peptic ulcer disease and gastric malignancy.

  2001cites this paper
• Non-steroidal anti-inflammatory drugs and gastrointestinal damage problems and solutions

  2001cites this paper
• Trends in Gastroenterology and Hepatology

  2001cites this paper
• The nonsteroidal anti-inflammatory drugs controversy.

  2000cites this paper
• How do NSAIDs cause ulcer disease?

  2000cites this paper
• Helicobacter pylori und nichtsteroidale Antirheumatika

  2000cites this paper
• Treatment of Helicobacter pylori infection.

  2000cites this paper
• Non‐steroidal anti‐inflammatory drugs, Helicobacter pylori and bleeding gastric ulcer

  2000cites this paper
• Non‐steroidal anti‐inflammatory drug toxicity in the upper gastrointestinal tract

  2000cites this paper
• Reply—On dissonances, Helicobacter pylori and NSAIDs

  2000cites this paper
• Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding.

  2000cites this paper
• Current problems with non-specific COX inhibitors.

  2000cites this paper
• Nonsteroidal anti-inflammatory drug-induced acute gastric injury in Helicobacter pylori gastritis in Mongolian gerbils.

  2000cites this paper
• [Helicobacter pylori and non-steroidal anti-inflammatory agents].

  2000cites this paper
• How does Helicobacter pylori infection interact with non-steroidal anti-inflammatory drugs?

  2000cites this paper
• Role of Helicobacter pylori infection in NSAID-associated gastropathy

  2000cites this paper
• Role of Helicobacter pylori in NSAID gastrophy: can H. pylori infection be beneficial?

  2000cites this paper
• Reply — Neutrophils in NSAID‐induced injury

  1999cites this paper
• Gastroduodenal mucosal defense.

  1999cites this paper
• Non‐steroidal anti‐inflammatory drugs inhibit Helicobacter pylori‐induced human neutrophil reactive oxygen metabolite production in vitro

  1999cites this paper
• Non-steroidal anti-inflammatory drug gastropathy and Helicobacter pylori infection.

  1999cites this paper
• Helicobacter pylori and gastro‐oesophageal reflux disease

  1999cites this paper
• [Should Helicobacter pylori infection be taken into account in the use of nonsteroidal anti-inflammatory agents?].

  1999cites this paper
• Treatment of Helicobacter pylori infection.

  1998cites this paper
• The treatment of peptic ulcer disease.

  1996cites this paper